This study used radiomics based on T2*-weighted imaging (T2*WI) and neurite orientation dispersion and density imaging (NODDI) to predict the short-term recovery of patients with cervical spondylotic myelopathy (CSM). By classifying patients into good and poor outcomes based on the 3-month recovery rate, we found both T2*WI- and NODDI-based radiomic features to have good prognostic power. Furthermore, radiomic score based on NODDI was an independent predictor, whereas the other features were not. These findings suggest that radiomics based on NODDI has good prognostic power for CSM.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords